← All stocks

TherapeuticsMD, Inc.

TXMD Net selling
CIK 0000025743 #4985 in the set updated 21 Sep 2026
Bought (120 mo)
$32.75M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$66.50M
$0.00 on a plan · $27.40M straight out of an exercise
Sold at will
$39.10M
14 of 73 sales
Net
−$33.75M
−$6.35M against sales at will

By person

21 insiders · 125 transactions
0.2×

Marlan D. Walker holds only 0.2 times base salary in stock. $123.00K of shares against $500.00K in salary for 2024.

Salary from the company's own proxy. The shares are what Marlan D. Walker last reported holding, valued at $1.67, the price Common Stock was last bought or sold at on the open market here, on 23 Dec 2025.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Milligan John C.K. IV
Secretary/CEO of subsidiary
$472.70K (4)
$10.80M (17) scheduled
−$10.32M
5,335,076
46.09%
$8.91M
−1.1%
Rubric Capital Management LP entity
Director
$29.67M (9)
$38.66M (1)
−$8.98M
2,946,908
25.46%
$4.92M
+174.3%
Bernick Brian
Co-Chief Executive Officer
$127.70K (2)
$7.90M (18) scheduled
−$7.78M
6,567,243
56.74%
$10.97M
−2.1%
Finizio Robert G
CEO
$549.98K (7)
$7.72M (17) scheduled
−$7.17M
19,991,637
$33.39M
−2.0%
Collins Cooper C.
Director
$1.52M (8)
+$1.52M
60,516
0.5228%
$101.08K
Krassan Mitchell
Chief Strategy Officer
$676.92K (1) scheduled
−$676.92K
0
0.0000%
$0.00
Cartwright Daniel A
Chief Financial Officer
$376.80K (2) scheduled
−$376.80K
40,000
0.3456%
$66.81K
0.0%
Thompson Tommy G
Director
$145.37K (10)
+$145.37K
25,181
0.2176%
$42.06K
Russell Angus C.
Director
$126.60K (3)
+$126.60K
5,792
0.0500%
$9.67K
MUSING JULES A.
Director
$100.92K (1)
−$100.92K
4,022
0.0347%
$6.72K
Bisaro Paul
Director
$96.50K (2)
+$96.50K
5,922
0.0512%
$9.89K
DArecca James
Chief Financial Officer
$81.20K (1)
−$81.20K
123,830
1.07%
$206.83K
Walker Marlan D
Chief Executive Officer
$2.48K (3)
$75.60K (5)
−$73.12K
73,639
0.6362%
$123.00K
BORKOWSKI EDWARD
EVP, Operations
$46.02K (1)
−$46.02K
59,248
0.5119%
$98.96K
Donegan Michael C
Prin. Fin. and Acctg. Officer
$40.94K (7) scheduled
−$40.94K
61,853
0.5344%
$103.31K
Ling Karen
Director
$25.08K (1)
+$25.08K
4,591
0.0397%
$7.67K
Naughton Gail K
Director
$20.64K (1)
−$20.64K
8,500
0.0734%
$14.20K
Barlow Jane F
Director
$10.00K (1)
+$10.00K
3,144
0.0272%
$5.25K
Glickman Mark A
Co-Chief Executive Officer
$2.17K (1) scheduled
−$2.17K
1,294
0.0112%
$2.16K
CARROLL J MARTIN
Director
106,864
0.9233%
$178.49K
+968.6%
ZIEGLER JOSEPH
Principal Financial Officer
7,500
0.0648%
$12.53K
Insider
Date
Role
Action
Shares
Price
Amount
Milligan John C.K. IV
4 Mar 2021
President/Secretary
Exercised, kept
179,000
$0.24
$43.75K
Finizio Robert G
4 Mar 2021
CEO
Exercised, kept
179,000
$0.24
$43.75K

What was left out

Form 4 filings counted 220
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 9
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 59
Sales at will 14
Transactions with no price 0
Shares from compensation/vesting 11,352,412
Sales filed before the plan box existed 12
History held since 22 Dec 2016